Look out, Sanofi and Regeneron: Pfizer is on the scene in atopic dermatitis with another blockbuster-to-be.  Friday, the FDA approved the New York drugmaker’s oral daily JAK1 inhibitor Cibinqo to treat adults with moderate to severe atopic dermatitis who have not been able to get their disease under control with other medicines including biologics and
0 Comments
The scandal surrounding Novak Djokovic’s entry into Australia, following his vaccine exemption, has sparked outcry on both a national and global scale.  This has led many in the UK to wonder – if Djokovic had been heading for SW19 this winter, what would be the outcome? While the sports star has remained elusive about his vaccination
0 Comments
Recently, there has been growing demand for DeNOx catalysts that can treat nitrogen oxides (NOx) at low temperatures, to increase energy efficiency when processing flue gas in industrial combustion facilities. NOx are emitted during the combustion of fossil fuels and are the leading cause of ultrafine particles (UFPs) formed via chemical reactions in the atmosphere.
0 Comments
Study design AAT was produced by decellularizing adipose tissue using a combination of mechanical and chemical processing steps, and the material was characterized to determine physical and biochemical properties. In vitro studies evaluated adipogenesis and migration of cells in response to AAT, while in vivo biocompatibility, volume retention, and local immune cell populations infiltrating subcutaneously
0 Comments
The founder of Moderna’s incubator, Flagship Pioneering, penned his first annual letter charting the four driving forces behind the biotech industry’s future with an emphasis on digital biology and platform technologies. Noubar Afeyan, Ph.D., who founded Flagship in 2000 and is its CEO as well as chairman of Moderna, also called on governments and private sector
0 Comments
Vir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation to include the advancement of new innovations for HIV and malaria treatment. The new commitment from the Bill & Melinda Gates Foundation supports the development of Vir Biotech’s ‘vaccinal antibody’ technology, a significant tool in combatting
0 Comments
Since December 2019, Wuhan, China, has been conducting influenza and related disease monitoring, and a number of cases of viral pneumonia have been discovered, all of which have been diagnosed as viral pneumonia or pulmonary infection. The World Health Organization (WHO) designated it a novel coronavirus (2019-nCoV) on January 12, 2020. The coronavirus Research Group dubbed
0 Comments
The computational neuroscientist Professor Alexander Ecker from the University of Göttingen and the Max Planck Institute for Dynamics and Self-Organization (MPIDS) has received a Starting Grant from the European Research Council (ERC). The ERC has awarded his project “Deep Neuron Embeddings: Data-driven multi-modal discovery of cell types in the neocortex” a total of 1.5 million
0 Comments
Determination of CD44 and EpCAM antigen levels in MCF7 cells We examined the labeling efficiency of MCF7 cells, the most common breast cancer cells, with anti-CD44 ab and anti-EpCAM ab43. Briefly, cultured MCF7 cells were labeled by incubation with Syto-13 nucleus-staining dye, QD585-anti-CD44 ab, and QD655-anti-EpCAM ab. The details of the cell culture condition, ab
0 Comments
After a false start in Europe, bluebird bio is determined to give its trio of gene therapies a better shot in the U.S.  Bluebird is readying the commercial nest ahead of a May decision on its beta thalassemia gene therapy beti-cel, also known as Zynteglo. Those preparations will be “crucial” to unlocking the blockbuster potential
0 Comments
AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria. The results from the trial immunogenicity and safety trial, D7220C00001, reveal that the vaccine generated a higher antibody response against the Omicron variant as well as others, including Beta, Delta, Alpha, and Gamma, according to Reuters. An increased
0 Comments